Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Neurological Research|May 12, 2006
The role of CD4+ T-cells in the development of MSSylvia Delgado, William A SheremataParkinsonism & Related Disorders|December 11, 2002
Transient movement disorders and multiple sclerosisAlireza Minagar, William A Sheremata, William J WeinerAnnals of Epidemiology|December 26, 2001
Epidemiologic features of HTLV-II: serologic and molecular evidenceGeorge W Lowis, William A Sheremata, Alireza MinagarCNS Drugs|November 5, 2005
The role of alpha-4 integrin in the aetiology of multiple sclerosis: current knowledge and therapeutic implicationsWilliam A Sheremata, Alireza Minagar, J Steven Alexander, et al.Archives of Neurology|January 11, 2012
Association between paroxysmal tonic spasms and neuromyelitis opticaNida Usmani, Gurdesh Bedi, Byron L Lam, et al.Journal of Neurovirology|May 11, 2010
Human T-lymphotropic virus type I or II (HTLV-I/II) associated with recurrent longitudinally extensive transverse myelitis (LETM): two case reportsSilvia R Delgado, William A Sheremata, Andrew D Brown, et al.Journal of Neuroinflammation|September 6, 2006
Interferon-beta1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosisWilliam A Sheremata, Wenche Jy, Sylvia Delgado, et al.Journal of Neuroinflammation|July 1, 2008
Evidence of platelet activation in multiple sclerosisWilliam A Sheremata, Wenche Jy, Lawrence L Horstman, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|May 31, 2011
Impact of rituximab on relapse rate and disability in neuromyelitis opticaGurdesh S Bedi, Andrew D Brown, Sylvia R Delgado, et al.Frontiers in Bioscience : a Journal and Virtual Library|September 9, 2004
Endothelial microparticles (EMP) bind and activate monocytes: elevated EMP-monocyte conjugates in multiple sclerosisWenche Jy, Alireza Minagar, Joaquin J Jimenez, et al.Pageof 2